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The expression of transient receptor potential protein channels increases intensively colon and breast cancer cells. We 
aimed to reveal the role of 5-fluorouracil (5FU) and capecitabine along with Transient Receptor Potential Vanilloid 1 
(TRPV1) channels in breast and colon cancer cells. Breast (MCF-7) and colon (Caco-2) cells were cultured and the study 
was planned as 7 main groups. Cells in the group were incubated with 5FU and capecitabine for 24 h and then incubated 
with TRPV1 channel antagonist capsazepine and stimulator capsaicin. The effects of medicines were investigated on 
molecular pathways of apoptosis. It was concluded that the administration of TRPV1 channel stimulator capsaicin in both 
cancer cells significantly increased the degree of intracellular Ca2+ levels and apoptosis levels compared to the control group 
whereas, the use of TRPV1 channel inhibitor capsazepine, significantly decreased the degree of apoptosis levels. The 
apoptotic effects of 5FU and capecitabine on both colon and breast cancer cells are directly related to TRPV1 channels and 
TRPV1 channels play an important role in the apoptosis. The apoptotic cell lines activity of capecitabine was higher in 
breast cancer cells, while that of 5FU was more pronounced in colon cancer cells. 
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Breast and colon cancers are common and are among 
the significant causes of death worldwide. Breast 
cancer is the most common type of cancer among  
all cancers and is among the leading causes of  
cancer-related deaths in women
1
. Colon cancer is the 
third most common cancer in men, following lung and 
prostate cancers, and the second most common cancer 
in women, after breast cancer
2
. Chemotherapy in breast 
and colon cancer is often used in the preoperative and 
postoperative periods. Significant progress has been 
made in the treatment with the development of 
chemotherapy strategies that are applied depending on 
the various cancer subtypes and stages as a result of 
recent studies, especially breast cancer
3
. 
5-Fluorouracil (5FU) is one of the 
chemotherapeutic agents used in both colon and 
breast cancer. The most well-known antitumor effect 
of 5FU is to bind DNA and RNA and thereby to block 
DNA synthesis and cell proliferation. 5FU is widely 
used in head, neck, breast cancers and aerodigestive 
tract cancers with a broad spectrum of activity against 
solid tumors, alone or in combination chemotherapy
4
. 
Capecitabine is a prodrug used for treating metastatic 
and locally advanced breast cancers that do not 
respond to anthracycline or paclitaxel treatment.  
It is administered orally and metabolized and 
converted to 5FU, the active agent, in the liver
5
. 
Capecitabine is also used in the treatment of adjuvant 
and especially metastatic colon cancer and metastatic 
gastric cancer
6
.  
There are 6 subfamilies of mammalian TRP 
channels: TRPC (canonical), TRPV (vanilloid), 
TRPM (melastatin), TRPP (polycystin), TRPML 
(mucolipin) and TRPA (ankyrin)
7
. TRP channels are 
sensitive to stimuli such as temperature, pH, injury, 
cations, cytokines and mechanical stress
8
. Besides, 
TRP channels respond fairly well to oxidative stress 
mediators including reactive oxygen (ROS) and 
reactive nitrogen species (RNS) and other 
electrophiles
9
. 
The TRP protein family contains different groups 
with calcium ion (Ca
2+
) permeable and non-selective 
cation channels and is found in many living 
organisms. Intracellular Ca
2+
 plays an important role 
in oxidative stress and apoptosis as well as 
inactivation of TRP channels by receptor stimulation 
and enzymes such as Ca
2+
 dependent protein 
phosphatase
10
. It is known that chemotherapeutic 
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agents increase free oxygen radicals and intracellular 
Ca
2+
 levels in the cell and lead to oxidative stress. 
TRP channels have been reported to play an important 
role in the development of numerous diseases and  
one of these involves TRPV1 channels
11
. It has  
been reported that stimulation of TRPV1 channels 
induces apoptosis in many cancer cells such as 
osteosarcoma, colon, glioma, and pancreas, inhibiting 
the growth of cancer cells while preserving normal 
cells undamaged
12,13
. Similar effects of TRPV1 
channels have been also demonstrated in breast  
cancer cells
14
. 
In this study, we administered 5FU and 
capecitabine agents to colon and breast cell cancer 
cell cultures and investigated the role of TRPV1 
channels, which are known to be abundant in breast 
and colon cancer cells, and sensitive to oxidative 
stress. We also aimed at revealing the role of these 
drugs on TRPV1 channels and intracellular  
Ca
2+
 values. 
 
Materıals and Methods 
Cell culture, reagents, and dyes 
Human Breast Cancer (MCF-7) and Colon Cancer 
(Caco-2) cell lines were purchased from the Culture 
Collection of Animal Cells, Foot and Mouth  
Disease (ŞAP) Institute, Ankara, Turkey. MCF-7  
and Caco-2 cells were cultured in Roswell Park 
Memorial Institute-1640 (RPMI-1640) and 
Dulbecco’s modified Eagle’s medium (DMEM) 
respectively. All mediums containing 10% fetal 
bovine serum (FBS) (Fisher Scientific, and 1% 
penicillin/streptomycin (Thermo-Fischer). Cells were 
evenly distributed as 1 × 106 cells in each of 8-10 
flasks (filter cap, sterile, 5 mL, 25 cm
2
). Cells were 
incubated at 37°C at 5% CO2 in a humidified 
incubator. After cells have reached 75–85% 
confluence, cell was incubated with the chemical 
compounds described in the groups section. Cells 
were examined daily for evidence of contamination. 
After treatments, the cells were detached with % 0.25 
Trypsin–EDTA for analysis and split into the sterile 
falcon tubes for analyses. 
DMEM, RPMI 1640, Trypsin–EDTA, Fetal Bovine 
Serum, and penicillin-streptomycin and Dimethyl 
sulfoxide, Dihydrorhodamine-123 (DHR 123) were 
obtained from Sigma Aldrich (St. Louis, MO),  
Fura 2 (AM) calcium fluorescent dye was purchased 
from Calbiochem (Darmstadt, Germany). A 
mitochondrial stain 5,50, 6,60-tetrachloro-1,10,3,30-
tetraethyl benzimidazolyl carbocyanine iodide (JC-1) 
and Probenecid were obtained from Santa Cruz 
(Dallas, Texas, USA). Pluronic® F-127 was obtained 
from Biovision (San Francisco, USA). Caspase-3 
(AC-DEVD-AMC) and Caspase 9 (AC-LEHD-AMC) 
substrates were obtained from Enzo (Lausen, 
Switzerland). APOPercentage assay with releasing 
buffer was purchased from Biocolor (Belfast, 
Northern Ireland). 
 
Study Groups 
The study was planned as 7 main groups below: 
Group 1 (Control): None of the study drugs were used 
and were kept in a flask containing the same 
cell culture condition. 
Group 2 (Capec): Cells were incubated with 2 µM 
Capecitabine for 24 h
15
. 
Group 3 (Capec+Czpn): Cells were incubated with  
2 µM Capecitabine for 24 h and then 
incubated with TRPV1 channel antagonist 
Capsazepin (Czpn, 0.1 mM, 30 min). 
Group 4 (Capec+5FU): Cells were incubated with  
2 µM Capecitabine and 2,5 µM 5-Fluorouracil 
for 24 h. 
Group 5 (Capec+5FU+Czpn): Cells were incubated 
with 2 µM Capecitabine and 2,5 µM 5-
Fluorouracil for 24 h and then incubated with 
TRPV1 channel antagonist Capsazepin 
(Czpn, 0.1 mM, 30 min). 
Group 6 (5FU): Cells were incubated with 2,5 µM  
5-Fluorouracil for 24 h
16
. 
Group 7 (5FU+Czpn): Cells were incubated with  
2,5 µM 5-Fluorouracil for 24 h and then 
incubated with TRPV1 channel antagonist 
Capsazepin (Czpn, 0.1 mM, 30 min). 
For Apoptosis, Intracellular Reactive Oxygene 
Species, Mitochondrial depolarisation, Caspase 3 and 
Caspase9 experiments, the cells were further treated 
with TRPV1 channel agonist Capsaicin (Cpsin,  
0.1 mM, 10 min) for activation of TRPV1 channel 
before related analysis. During calcium signaling 
analysis (Fura-2/AM), cells were stimulated on 20
th
 
cycles with 0.1 mMCpsin in the existence of 1.2 mM 
Calcium and calcium free buffer in extracellular 
environment. 
 
Measurement of intracellular free calcium concentration 
([Ca2+]i) 
Intracellular free calcium concentration ([Ca
2+
]i) 
was measured with UV light excitable Fura 2 
acetoxymethyl ester as an intracellular free Ca
2+
 
indicator. After cell culture treatments, MCF-7 and 
Caco-2 cells were incubated with HEPES-buffered 
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saline [HBS; 5 mMKCl, 145 mMNaCl, 10 mM  
D-glucose, 1 mM MgCl2, 1,2 mM CaCl2, 10 mM 
HEPES and 0.1% (w/v) BSA); pH 7.4] containing  
5 μM fura-2 AM and 0.05% (w/v) Pluronic F-127 for  
1 h at 37°C in the dark. The loaded cancer cells were 
washed twice with HBS and covered with 1000 μL of 
HBS supplemented with 2.5 mM probenecid for at 
least 20 min at 37C in the dark to allow for Fura-2 
AM de-esterification. Cells were seeded in clear  
flat-bottom black 96-well culture trays (Grainer Cell 
Star, Life Sciences USA) at a density of 4 × 104 
cells/per well. Fluorescence emission intensity at  
510 nm was determined in individual wells using a 
plate reader equipped with an automated injection 
system (Synergy
TM
 H1, Biotek, USA) at alternating 
excitation wavelengths of 340 and 380 nm every 3 s 
for 50 acquisition cycles (cycle: 3 s; gain: 120) in 
response to agonists (Cpsin, 0.1 mM) added with the 
automated injector. [Ca
2+
]i in cells was expressed as 
the average emission at 510 nm in individual wells  
in response to excitation at 340 nm (Ca
2+
 bound)/ 
380 nm (Ca
2+ −
free Fura 2 AM) normalized to initial 
fluorescence emission obtained during the first  
20 cycles. Measurement of [Ca
2+
]i including staining 
process modification was performed according to the 
method of Martinez et al
17
. 
 
Intracellular ROS production measurement 
The cells (10
6
 cells/mL for per group) were 
incubated with 20 μM DHR 123 as florescent oxidant 
dye at 37°C for 25 min
18
. The Rh123 fluorescence 
intensities were determined by using an automatic 
microplate reader (Synergy
TM
 H1, Biotek, USA). 
Excitation and emission wavelengths of the analyses 
were 488 nm and 543 nm, respectively. We presented 
the data as a fold increase over the level before 
treatment. 
 
Assay for Apoptosis level, caspase 3 and caspase 9 activities  
The APOPercentage
TM
 which is used as an assay 
for the detection and quantification of apoptosis 
(Biocolor Ltd., Belfast, Northern Ireland) was 
performed according to the manufacturer’s 
instruction. APO Percentage dye is actively bound to 
phosphatidylserine lipids and transferred into the cells 
and apoptotic cells are stained red. The apoptosis 
analysis procedure was performed according to the 
manufacturer’s instruction and Özdemir et al19. The 
cells were analyzed for apoptotic cell detection by 
spectrophotometry (multiplate reader) at 550 nm 
(Synergy
TM
 H1, Biotek, USA). 
The methods of Caspase 3 and Caspase 9 activity 
were based on previously reported
20,21
. Caspase 3 
(AC-DEVD-AMC) and Caspase 9 (AC-LEHD-AMC) 
substrates cleavages were calculated with Synergy
TM
 
H1 microplate reader (Biotek, USA) with 360 nm and 
460 nm wavelengths (excitation/emission). The 
values were evaluated as fluorescent units/mg protein 
and shown as fold increase over the level before 
treatment (experimental/control). 
 
Mitochondrial membrane potential (JC-1) analyses 
The quantification of mitochondrial membrane 
depolarization was carried out by measuring the 
fluorescence intensity of the JC-1 a cationic dye 
which was measured by a single excitation 
wavelength of 485 nm (green) and the emission 
wavelength of 535 nm, the red signal at the 540 nm 
(excitation) and 590 nm (emission) the wavelengths 
(Synergy
TM
 H1, Biotek, USA)
22
. Data are presented as 
emission ratios (590/535). Mitochondrial membrane 
potential changes were quantified as the integral of 
the decrease in the JC-1 fluorescence ratio of 
experimental/control. 
 
Statistical analyses 
All results were expressed as means±standard 
deviation (SD). Significant values in the groups were 
assessed with one-way ANOVA. Statistical analyses 
were calculated using GraphPadPrism version 7.04 
for Windows (GraphPad Software, San Diego 
California, the USA). P <0.05 was considered 
significant. 
 
Results 
Effects of extracellular capecitabine and 5FU treatments on 
Cpsin-induced [Ca2+]i concentration through TRPV1 channels 
activation in the MCF-7 and Caco-2 cells 
As a result of administration of 5FU and 
capecitabine separately and together on breast cancer 
cell culture (MCF-7) and colon cancer cell culture 
(Caco-2), these chemotherapeutic agents increased the 
intracellular calcium levels by stimulation of TRPV1 
channels in both cancer cells statistically significantly 
compared to the control group (P ˂0.001 for MCF-7 
and Caco-2 cells). It was found that intracellular 
calcium levels were significantly increased by 
administration of TRPV1 channel stimulator capsaicin 
(Cpsin) in both cancer cells, more prominently in the 
combination of 5FU/capecitabine compared to the 
control group (P ˂0.001). On the other hand, 
intracellular calcium levels decreased at a significant 
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level with the use of the TRPV1 channel inhibitor 
capsazepine (Czpn) (P ˂0.001). These effects of 
combined use of 5FU and capecitabine were also 
found to be statistically significantly higher than a 
single use of these agents (stimulation: P ˂0.05, 
inhibition: P ˂0.001). It was also found that 5FU 
significantly increased intracellular Ca
2+
 levels in both 
cancer cells statistically compared to capecitabine  
(P <0.001) (Fig. 1) 
 
Results of apoptosis and intracellular ROS production values 
in MCF-7 and Caco-2 Cells 
Examination of apoptosis and intracellular Reactive 
Oxygen Species (ROS) levels with use of 5FU and 
capecitabine separately and together revealed that these 
chemotherapeutic agents led to significantly increased 
apoptosis and intracellular ROS levels in both cancer 
cells with use of TRPV1 channel stimulator (Cpsin) in 
the colon cancer than in the control group (P ˂0.05) 
and TRPV1 channel inhibitor (Czpn) markedly 
decreased apoptosis and intracellular ROS levels  
(P ˂0.001). This effect was found to be statistically 
significantly higher in the 5FU/capecitabine 
combination group than in the single-agent group  
(P ˂0.05). It was also seen that ROS levels in the  
breast cancer cells were significantly higher in  
the capecitabine-treated group compared to the  
5FU applied group, whereas in the colon cancer  
cells, they were significantly higher in the 5FU  
group (P ˂0.001). A comparison of the two drugs  
in terms of apoptosis level revealed that apoptosis 
levels in the 5FU group of breast cancer cells  
were lower (P ˂0.05) than that of capecitabine, 
whereas apoptosis levels in colon cancer cells  
were found to be statistically higher in 5FU group  
(P <0.001). (Fig. 2)  
 
Results of Mitochondrial Membrane Depolarization (JC-1) 
and Caspase 3 and Caspase 9 levels in MCF-7 and Caco-2 
Cells 
As a result of examination of mitochondrial 
depolarization, Caspase 3 and Caspase 9 levels by  
administration of application of 5FU and 
capecitabine, it was found that these 
 
 
Fig. 1 — In vitro effect of Capecitabine (2 µM, 24 h) and 5FU (2,5 µM, 24 h) on the free intracellular calcium increase ([Ca2+]i) through 
TRPV1 channels in MCF-7 (A) and Caco-2 (B) cells and cellular calcium ion release (C). (n=3 and mean ± SD). The cells are stimulated 
by capsaicin (Cpsin and 0.1 mM on the 20th cycle) but they were inhibited by capsazepine (Czpn and 0.1 mM for 30 min). aP ˂0.001 and 
bP ˂0.05 vs control, cP ˂0.05, and dP ˂0.001 vs Capec, eP ˂0.001 vs Capec+5FU, fP ˂0.001 vs 5FU 
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chemotherapeutic agents increased mitochondrial 
depolarization, Caspase 3 and Caspase 9 levels in 
both cancer cells with application of TRPV1 channel 
stimulator (Cpsin), being more prominent in colon 
cancer (P ˂0.05) and TRPV1 channel inhibitor (Czpn)  
showed a significant decrease in mitochondrial 
depolarization, Caspase 3 and Caspase 9 levels  
(P ˂0.001). These effects were found to be 
statistically significantly higher in the 
5FU/capecitabine combination group than in the 
single-use group. (P ˂0.05 for mitochondrial 
depolarization, P ˂0.001 for caspase 3 and caspase 9). 
It was also found that capecitabine significantly 
increased mitochondrial depolarization levels in both 
cancer cells statistically significantly compared to 
5FU (P ˂0.05). When these two drugs were compared 
in terms of caspase 3 and caspase 9 levels, caspase 3 
levels were lower in the 5FU group compared to 
capecitabine in both cancer cells (P ˂0.001) and 
caspase 9 levels were lower in the 5FU group than 
capecitabine in breast cancer cells, while caspase 9 
levels were found to be statistically significantly 
higher in the 5FU group than in the capecitabine 
group in colon cancer cells (P ˂0.001) (Fig. 3).  
Table 1 shows a comparison of cytosolic  
calcium, ROS, caspase 9, caspase 3, mitochondrial 
depolarization and apoptosis levels in study  
groups. And (Table 2) shows  the effects  of 5FU  and  
 
 
 
Fig. 2 — The effect of Capecitabine (2 µM, 24 h) and 5FU (2,5 µM, 24 h) on (A) Apoptosis levels; (B) Reactive Oxygene Species; and 
(C) Mitochondrial Depolarization levels in the MCF-7 and Caco2 cells (mean ± SD and n=10). ). aP ˂0.001 vs control, bP ˂0.05 and  
cP ˂0.001 vsCapec, dP ˂0.05 and eP ˂0.001 vs Capec+5FU and fP ˂0.05 vs 5FU and gP ˂0.05 vs 5FU 
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Fig. 3 — The effect of Capecitabine (2 µM, 24 h) and 5FU (2,5 µM, 24 h) on Caspase 3 (A) and Caspase 9 (B) levels in the MCF-7 and 
Caco2 cells (mean ± SD and n=10). aP ˂0.001 and bP ˂0.05 vs control, cP ˂0.05 and dP ˂0.001 vsCapec, eP ˂0.05 and fP ˂0.001 vs 
Capec+5FU, gP ˂0.05 and hP ˂0.001 vs 5FU 
 
Table 1 — Comparison of cytosolic calcium, ROS, caspase 9, caspase 3, mitochondrial depolarization and apoptosis levels  
with standard deviation in study groups 
 Calcium Signaling ROS Mitoc. Dep. Caspase 3 Caspase 9 Apoptosis 
Control 
MCF-7 1± 0,202 1 ± 0,007 1 ± 0,015 1 ± 0,011 1 ± 0,016 1 ± 0,008 
Caco-2 1 ± 0,181 1 ± 0,015 1 ± 0,010 1 ± 0,02 1 ± 0,012 1 ± 0,016 
       
Capec 
MCF-7 1,352 ± 0,336 1,635 ± 0,058 1,667 ± 0,027 2,306 ± 0,057 1,759 ± 0,007 1,495 ± 0,011 
Caco-2 1,509 ± 0,287 1,574 ± 0,019 2,059 ± 0,020 2,394 ± 0,029 1,819 ± 0,005 1,559 ± 0,020 
       
Capec+Czpn 
MCF-7 1,159 ± 0,262 1,349 ± 0,018 1,673 ± 0,027 2,154 ± 0,009 1,57 ± 0,037 1,394 ± 0,028 
Caco-2 1,209 ± 0,286 1,275 ± 0,0016 1,94 ± 0,017 2,09 ± 0,09 1,7 ± 0,012 1,361 ± 0,019 
       
Capec+5FU 
MCF-7 2,175± 0,426 1,872 ± 0,010 2,201 ± 0,046 2,558 ± 0,019 1,908 ± 0,018 1,817± 0,005 
Caco-2 2,661 ± 0,424 2,772 ± 0,014 2,517 ± 0,037 2,779 ± 0,005 2,159 ± 0,013 2,116 ± 0,049 
       
Capec+5FU+Czpn 
MCF-7 1,896 ± 0,339 1,664 ± 0,023 1,806 ± 0,019 2,243 ± 0,018 1,753 ± 0,014 1,748 ± 0,033 
Caco-2 2,316 ± 0,415 2,006 ± 0,067 2,29 ± 0,016 2,519 ± 0,020 2,004 ± 0,031 1,958 ± 0,021 
       
5FU 
MCF-7 1,795 ± 0,512 1,469 ± 0,035 1,568 ± 0,021 1,389 ± 0,015 1,657 ± 0,018 1,445 ± 0,022 
Caco-2 1,815 ± 0,342 1,958 ± 0,017 1,726 ± 0,019 1,797 ± 0,010 1,988 ± 0,015 1,785 ± 0,032 
       
5FU+Cpzn 
MCF-7 1,724 ± 0,470 1,325 ± 0,023 1,439 ± 0,016 1,125 ±0,015 1,508 ± 0,017 1,369 ± 0,024 
Caco-2 1,581 ± 0,422 1,786 ± 0,017 1,594 ± 0,014 1,311 ± 0,013 1,841 ± 0,013 1,648 ± 0,025 
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Table 2 — The apoptotic efficiency of 5FU and capecitabine on breast and colon cancer cells 
BREAST (MCF-7)  COLON (Caco-2) P 
5FU Capecitabine  5FU Capecitabine 
High  Ca2+concentration High  ˂0.001 
 High Intracellular ROS High  ˂0.001 
 High Mitochondrial Depolarisation  High ˂0.05 
 High Caspase 3  High ˂0.001 
 High Caspase 9 High  ˂0.001 
 High Apoptosis High  ˂0.05/˂0.001 
 
capecitabine on the molecular pathway of apoptosis in 
breast and colon cancer cells. 
 
Discussion 
Breast and colon cancers are the most common 
cancers in the world. In the treatment of both 
cancers, various chemotherapy protocols are widely 
used in preoperative and postoperative periods. 5FU 
and capecitabine, are the two most commonly used 
chemotherapeutic agents in colon and breast 
cancers
4,5
. Capecitabine is a chemotherapy agent that 
is precursor of 5FU and used orally. Oral use of 
cabecitabine has important advantages such as ease 
of use, lack of complications that may develop due 
to intravenous drug administration, positive effects 
on patient's quality of life, and pharmacoeconomic 
reasons (i.e. drug cost, no need for hospitalization, 
etc.). However oral use has some disadvantages  
such as the unclarity of drug- taking by the patients 
inappropriate dosage and period and difficult 
controllability of this condition
6,
. It has been 
reported that 5FU induces apoptosis in cancer cells 
by increasing the amount of intracellular ROS, this 
effect is dose and time. As a result of increasing 
intracellular ROS levels, damage some cellular 
macromolecules, depletion of endogenous antioxidants 
and oxidative stress begins which results in irreversible 
changes in components such as intracellular lipids, 
proteins, nucleic acids
23,24
. 
Several studies revealed the effects of subtypes  
of TRP channels on many different cancer cells and the 
relationship between the survival and the expression 
of TRP channels in these cancers have been 
demonstrated
25
. Furthermore, many recent studies 
have shown abnormal TRP channel expression in 
different types of cancer, and TRP channels have been 
reported to have effects on invasion, proliferation, 
differentiation, and tumor vascularization in cancer 
cells
13
. There are also studies conducted on the 
relationship between TRP channels colorectal
26
 and 
breast cancer. TRPC1, TRPM2, TRPM7, TRPV2, 
TRPV4, and TRPV6 channels were shown to be 
present normal mammary tissue and their 
overexpression in breast cancer cells was reported
13,27
. 
In a study of patients with colorectal cancer, it was 
reported that mRNA expression levels in TRPV3, 
TRPV4, TRPV5, TRPM4 and TRPC6 genes in cancer 
cells were lower than in normal cells
28
. TRPV1 
channels have also been found to be present in 
different numbers of breast cancer cell subtypes 
compared to normal cells and TRPV1 channel 
activation in breast cancer cells was reported to play 
an important role in all stages of the molecular 
pathway of apoptosis by increasing intracellular Ca
2+
 
levels
14,29
. TRPV1 channels were used in this study 
because it has been shown that these channels 
commonly expressed in both colon and breast cancers 
and play a role in tumor proliferation in both 
cancers
12,30
. 
It is known that intracellular Ca
2+
 levels have a 
significant impact on cancer cells and TRP channels, 
and they have important roles in intracellular 
oxidative stress and apoptosis. Ca
+2 
channels play an 
important role in cell proliferation, migration, 
apoptosis and diferentiation
31
. It has been shown that 
all TRP channels are cation permeable and alter 
intracellular calcium concentrations and they have an 
influence on the regulation of Ca
2+
 release in 
numerous cell organelles
32
. The increase of 
intracellular calcium level leads to an increase of ROS 
amount, mitochondrial membrane depolarization and 
apoptosis in cancer cells. Elevation of intracellular 
ROS triggered oxidative stress and can cause 
dangerous process such as oxidative modification of 
intracellular nucleic acids and proteins
33
.Intracellular 
Ca
2+
 concentration is variable and has been reported 
to increase in cases such as increased proliferation 
and abnormal differentiation which are indicative of 
cancer invasion
11
. 
In our study, 5FU and capecitabine were 
administered separately and in combination with 
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breast cancer cell culture (MCF-7) and colon cancer 
cell culture (Caco-2). Then the effects of these 
chemotherapeutic agents on TRPV1 channels and the 
effects of these channels on apoptosis were 
investigated. A specific stimulator (Cpsin) and 
inhibitor (Czpn) for TRPV1 channels were 
administered and the intracellular Ca
2+
 level, 
mitochondrial depolarization, caspase 3 and 9 values 
and intracellular ROS levels, all of which are 
intermediate stages of apoptosis of cancer cells, as 
well as degree of apoptosis were investigated and 
results were compared with the control group. As a 
result of the analysis, it was found that the use of both 
drugs resulted in TRPV1 channel activation and  
that there was a significant increase in intracellular 
calcium levels, mitochondrial depolarization  
and intracellular ROS levels mediated by  
TRPV1 channels. In the 5FU, 5FU+capecitabine 
groups oxidative stress-induced apoptosis levels were 
significantly increased compared to the control group. 
In conclusion, TRPV1 channel activation resulted in a 
statistically significant increase in intracellular 
calcium levels resulting in higher mitochondrial 
depolarization and intracellular ROS levels and 
degree of apoptosis in compared to the control group. 
As a result of TRPV1 channel inhibition, these effects 
were significantly reduced and apoptosis levels were 
found to be statistically significantly decreased 
compared to the control group. 
Also, as result of this study, when the apoptotic 
effects of 5FU and capecitabine were compared, it 
was found that capecitabine had a statistically 
significantly higher effect than 5FU on breast cancer 
cells which are related to the molecular pathways of 
apoptosis by elevating intracellular levels of 
increasing mitochondrial depolarization and caspases 
3 levels. 5FU has been shown to have a statistically 
significant higher level of efficacy on intracellular 
ROS, caspase 9, and apoptosis levels in colon cancer 
cells and a statistically significant higher level of 
intracellular Ca
2+
 concentration in both cancer cells 
than the capacitabine (Table 1). 
Although there are studies in the literature 
investigating the relation and role of TRP channels in 
different types of cancers, a limited number of studies 
have examined the effects of chemotherapeutic agents 
on TRP channels in colon and breast cancers. It has 
been reported that the distal gastrointestinal tract is 
intensely sensitive to TRPV1 sensory neurons, 
extrinsically and primarily
34
. Accordingly, it has been 
reported that neuropeptides released by triggering 
TRPV1 channels increase neurogenic inflammation 
and may play a role in the development of colorectal 
cancer
30
. It has also been found that TRPV1 channels 
have immunoregulatory roles in the intestinal mucosa 
due to their effects on inflammatory cells and 
consequently alter the tumor micro-environment
34
. In 
a study of the effects of chemotherapeutic agents on 
TRP channels, it was shown that TRPC5 plays an 
important role in 5FU chemoresistant colon cells
32
. In 
another study about the impact of 5FU on breast 
cancer cell culture on TRP channels and cell death, 
similar to our study, it was demonstrated that 5FU has 
similar effects on all stages of the molecular pathway 
of apoptosis by increasing intracellular Ca
2+
 levels by 
TRPV1 channel activation
29
. 
 
Conclusion 
The  results of this study suggest that the apoptotic 
effects of 5FU and capecitabine, agents frequently 
used for colon and breast cancer, on tumor cells are 
directly related to the TRPV1 channels and that these 
channels play an important role in all molecular 
pathways of apoptosis by elevating intracellular levels 
of Ca
2+
. TRPV1 channels have been shown to play 
crucial roles in tumor proliferation and development 
and exert significant effects on oxidative stress and 
cell death in tumor cells during chemotherapy. 
Further, the apoptotic activity of capecitabine, a 
precursor of 5FU, was observed to be higher in breast 
cancer cells, while that of 5FU was more pronounced 
in colon cancer cells. 
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